Guidelines International Network | Guidelines International Network (GIN)

CFTR-Modulatortherapie bei Mukoviszidose. S3-LL (DGP, GPP)

MeSH Terms
Guideline Contact: Ina Kopp ([email protected])
English Title Translation: CFTR modulator therapy for cystic fibrosis - Living Guideline
Expected Publication Date: 31/12/2028
Publication Scope: management
Countries of Application: Germany
Guideline Publication Status: Development
Languages: German
Authors: AWMF (DE)

Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges (NG11)

MeSH Terms: Behavioral Symptoms (F01.145.126); Neurologic Manifestations (C10.597); Neurologic Manifestations (C23.888.592)
Publication Scope: management
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2015

Changing Practice: Appraising Systematic Reviews (Best Practice 4(1Suppl.1))

MeSH Terms: Methodological Study (E05.581)
Publication Scope: management
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: JBI (AU)
Publication Year: 2000

Changing Practice: Introduction to Systematic Reviews (Best Practice 5(1Suppl.1))

MeSH Terms: Methodological Study (E05.581)
Publication Scope: management
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: JBI (AU)
Publication Year: 2001

Check-list de sortie d'hospitalisation supérieure à 24h

MeSH Terms: Patient Discharge (E02.760.400.610); Patient Discharge (N02.421.585.400.610)
Publication Scope: assessment; counselling; implementation; management; patient_education; prevention; prognosis; rehabilitation; screening; treatment
Countries of Application: France
Guideline Publication Status: Published
Languages: French
Authors: HAS (FR)
Publication Year: 2015

Chemo- and Targeted Therapy for Patients With HER2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline

Guideline Contact: [email protected]
Publication Date: 29-Jul-21
Date of Last Evidence Search: 13-May
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2021

Chemo- and Targeted Therapy for Women with HER2 Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

MeSH Terms: Neoplasms (C04); Breast Neoplasms (C04.588.180)
Guideline Contact: [email protected]
Publication Date: 02-Sep-14
Publication Scope: implementation; patient_education
Countries of Application: United States
Guideline Publication Status: Under Review
Languages: English
Authors: ASCO (US)
Publication Year: 2014

Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update

Guideline Contact: [email protected]
Publication Date: 12-Dec-22
Date of Last Evidence Search: 2022
Countries of Application: United States
Languages: English
Authors: ASCO (US)
Publication Year: 2022

Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Guideline Contact: [email protected]
Publication Date: 06-Jan-21
Date of Last Evidence Search: 20-Aug
Publication Scope: treatment
Countries of Application: International; United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2021

Chest pain of recent onset: assessment and diagnosis (CG95)

MeSH Terms: Cardiovascular Diseases (C14); Signs and Symptoms (C23.888); Heart Diseases (C14.280); Pain (C23.888.646)
Publication Scope: assessment; management
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2010